Designing Educational Interventions for the Timely Diagnosis of Pediatric Cancer [0.03%]
儿童癌症及时诊断的教育干预设计
Fair Berg,Margit Mikkelsen,Matthew Kelleher et al.
Fair Berg et al.
Clinical Characterization of FGFR-Altered Pediatric Low-Grade Gliomas [0.03%]
FGFR基因突变的儿童低级别胶质瘤临床特征分析
Benjamin Posorske,Elizabeth S Borden,Shea Gallus et al.
Benjamin Posorske et al.
Pediatric low-grade gliomas (pLGG) are the predominant childhood central nervous system tumors. While BRAF alterations are known to drive the majority of pLGGs, a subgroup contains activating mutations or fusions involving FGFR1/2/3. FGFR i...
Early Impact of Childhood Opportunity on Neurocognitive Outcomes in Sickle Cell Disease [0.03%]
儿童期机会对镰状细胞病神经认知结果早期影响
Julia E LaMotte,Hannah Koch,Olivia A Coughlin et al.
Julia E LaMotte et al.
Introduction: Neurocognitive impairment is a well-recognized complication of sickle cell disease (SCD) that begins early in childhood and persists across development. While cerebrovascular injury contributes substantially...
Comment on: Scaling-Up Research in Childhood Cancer in Low- and Middle-Income Countries-Beyond Local Data to Local Leadership [0.03%]
对低收入和中等收入国家儿童癌症研究扩大化的评论-超越本地数据实现本地领导力
Mariana Bohns Michalowski,Vinicius Farias Campos,Ricardo Fernández-Ramires et al.
Mariana Bohns Michalowski et al.
The VIVA Regimen (Vinorelbine, Ifosfamide, Vincristine, and Actinomycin-D) for High-Risk Rhabdomyosarcoma: Feasibility and Outcomes From a Single-Institution Study [0.03%]
含伏立尼布、异环磷酰胺、长春新碱和放线菌素D的VIVA方案治疗高危横纹肌肉瘤：单中心可行性研究及疗效分析
Andrea Ferrari,Stefano Chiaravalli,Walter Ferrari Bravo et al.
Andrea Ferrari et al.
Introduction: Rhabdomyosarcoma is a highly chemosensitive tumor; however, high-risk and metastatic cases require more effective systemic treatments. This study evaluates the feasibility and efficacy of the "VIVA" regimen ...
Circulating Tumor DNA as a Potential Biomarker for Extracranial Disease Monitoring in Pediatric Melanoma: A Case Report [0.03%]
儿童黑色素瘤外颅疾病监测的循环肿瘤DNA潜在生物标志物地位的一项病例报告
Daniel E McLoughlin,Catherine K Gestrich,Brittani K N Seynnaeve et al.
Daniel E McLoughlin et al.
Art-Based Therapy in Paediatric Oncology: Alleviating Procedural Pain and Distress in Paediatric Patients With Acute Lymphoblastic Leukaemia-A Pilot Study [0.03%]
以艺术为基础的儿童肿瘤治疗：减轻急性淋巴细胞白血病患儿痛苦和焦虑的试点研究
Kavitha Dhanaraj,Surendran Veeraiah,Vidhya Gopalakrishnan et al.
Kavitha Dhanaraj et al.
Background and objectives: Paediatric patients undergoing treatment for acute lymphoblastic leukaemia (ALL) frequently experience significant pain and emotional distress related to procedures. While pharmacological manage...
Required Reconsideration of Periprocedural Resuscitation Status: Can Ethics Principles Inform Institutional Practice? [0.03%]
关于术前术后复苏状态的伦理原则再思考：伦理学原理能否指导机构实践？
Rachel Jalfon,Meaghann S Weaver,Deena R Levine et al.
Rachel Jalfon et al.
National guidelines recommend the opportunity to reconsider existing Do-Not-Resuscitate (DNR) orders periprocedurally rather than automatic suspension of DNR orders. We retrospectively reviewed records for oncology patients with active DNR ...
Leukemia and Exposure to Potential Benzene Sources in Children From the Mexico City Metropolitan Area, 2010-2021: A Geospatial Analysis [0.03%]
墨西哥城地区2010-2021年儿童白血病与接触潜在苯来源的地理空间分析
Orlando Rivera Zurita,Norma Candelaria López Santiago,Claudia Maria García Cuellar et al.
Orlando Rivera Zurita et al.
Background: Leukemia is the most common childhood cancer in Mexico, and acute lymphoblastic leukemia (ALL) is the most frequent subtype. Exposure to high concentrations of benzene has been associated with ALL incidence, p...
Transdifferentiation of Pediatric Pre-B-ALL Into Histiocytic Sarcoma Harboring BRAF and FLT3 Mutations: Durable Remission With MEK Inhibition, Surgery, and Allogeneic Stem Cell Transplantation [0.03%]
携带BRAF和FLT3突变的儿童Pre-B-ALL转分化为组织细胞肉瘤：MEK抑制、手术及allo-SCT诱导长期缓解
Kaisa Vepsälainen,Carl E Allen,Stefan Becker et al.
Kaisa Vepsälainen et al.